These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17975143)

  • 21. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
    Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
    Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P53 overexpression in nasopharyngeal carcinoma.
    Agaoglu FY; Dizdar Y; Dogan O; Alatli C; Ayan I; Savci N; Tas S; Dalay N; Altun M
    In Vivo; 2004; 18(5):555-60. PubMed ID: 15523893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic implications of Fas-ligand expression in nasopharyngeal carcinoma.
    Ho SY; Guo HR; Chen HH; Hsiao JR; Jin YT; Tsai ST
    Head Neck; 2004 Nov; 26(11):977-83. PubMed ID: 15390195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma.
    Zhou B; Rao L; Li Y; Gao L; Wang Y; Chen Y; Xue H; Song Y; Peng Y; Liao M; Zhang L
    Cancer Lett; 2009 Mar; 275(1):72-6. PubMed ID: 19006646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retropharyngeal nodal metastasis related to higher rate of distant metastasis in patients with N0 and N1 nasopharyngeal cancer.
    Tham IW; Hee SW; Yap SP; Tuan JK; Wee J
    Head Neck; 2009 Apr; 31(4):468-74. PubMed ID: 19189339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
    Lee CC; Chu ST; Chou P
    Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging : prognostic value and staging categories.
    Tang L; Li L; Mao Y; Liu L; Liang S; Chen Y; Sun Y; Liao X; Tian L; Lin A; Liu M; Ma J
    Cancer; 2008 Jul; 113(2):347-54. PubMed ID: 18459174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis.
    Chang KP; Wu CC; Chen HC; Chen SJ; Peng PH; Tsang NM; Lee LY; Liu SC; Liang Y; Lee YS; Hao SP; Chang YS; Yu JS
    Proteomics; 2010 Jul; 10(14):2644-60. PubMed ID: 20461718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis.
    Lin YS; Lin LC; Lin SW
    Laryngoscope; 2009 Jul; 119(7):1348-52. PubMed ID: 19402154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.
    Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ
    J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic influence of parapharyngeal extension in nasopharyngeal carcinoma.
    Ho HC; Lee MS; Hsiao SH; Hwang JH; Hung SK; Lee CC; Chou P
    Acta Otolaryngol; 2008 Jul; 128(7):790-8. PubMed ID: 18568523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combination of polymorphisms within MCP-1 and IL-1beta associated with ulcerative colitis.
    Li KS; Wang BY; Liu SY; Yao SP; Guo L; Mao DW
    Int J Immunogenet; 2009 Jun; 36(3):135-9. PubMed ID: 19392835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for recurrence and survival rate.
    Chu ST; Wu PH; Chou P; Lee CC
    Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S115-20. PubMed ID: 18236065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic impact of magnetic resonance imaging-detected cranial nerve involvement in nasopharyngeal carcinoma.
    Liu L; Liang S; Li L; Mao Y; Tang L; Tian L; Liao X; Cui C; Lin A; Ma J
    Cancer; 2009 May; 115(9):1995-2003. PubMed ID: 19235251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The time frame of Epstein-Barr virus latent membrane protein-1 gene to disappear in nasopharyngeal swabs after initiation of primary radiotherapy is an independently significant prognostic factor predicting local control for patients with nasopharyngeal carcinoma.
    Lin SY; Chang KP; Hsieh MS; Ueng SH; Hao SP; Tseng CK; Pai PC; Chang FT; Tsai MH; Tsang NM
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1339-46. PubMed ID: 16169672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A functional single nucleotide polymorphism site detected in nasopharyngeal carcinoma-associated transforming gene Tx.
    Ren W; Zheng H; Li M; Deng L; Li XL; Pan KF; Lu YY; Cao Y
    Cancer Genet Cytogenet; 2005 Feb; 157(1):49-52. PubMed ID: 15676147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients.
    Farhat K; Hassen E; Bouzgarrou N; Gabbouj S; Bouaouina N; Chouchane L
    Cytokine; 2008 Aug; 43(2):132-7. PubMed ID: 18555694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
    Lin S; Pan J; Han L; Zhang X; Liao X; Lu JJ
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1071-8. PubMed ID: 19362784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer.
    Chang SC; Lin PC; Yang SH; Wang HS; Li AF; Lin JK
    Ann Surg Oncol; 2009 Aug; 16(8):2323-30. PubMed ID: 19472013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of a correlation between the presence of a single nucleotide polymorphism in the matrix metalloproteinase 1 promoter and outcome in patients of chondrosarcoma.
    Fong YC; Dutton CM; Cha SS; Garamszegi N; Sim FH; Scully SP
    Clin Cancer Res; 2004 Nov; 10(21):7329-34. PubMed ID: 15534109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.